{
    "id": 30368,
    "fullName": "AICDA positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "AICDA positive indicates the presence of the AICDA gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 57379,
        "geneSymbol": "AICDA",
        "terms": [
            "AICDA",
            "AID",
            "ARP2",
            "CDA2",
            "HEL-S-284",
            "HIGM2"
        ]
    },
    "variant": "positive",
    "createDate": "06/24/2019",
    "updateDate": "06/24/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17392,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CYT01B demonstrated anti-tumor activity correlated with Aicda (Aid) expression level in tumor cell lines in culture and in patient derived xenograft (PDX) models (AACR Annual Meeting 2019, Abstract 4370).",
            "molecularProfile": {
                "id": 32534,
                "profileName": "AICDA positive"
            },
            "therapy": {
                "id": 8486,
                "therapyName": "CYT01B",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15414,
                    "pubMedId": null,
                    "title": "A novel RAD51 inhibitor, CYT01B, shows anti-cancer activity in preclinical models of AID expressing solid tumors",
                    "url": "https://www.abstractsonline.com/pp8/#!/6812/presentation/5491"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32534,
            "profileName": "AICDA positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}